China may join TPP talks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

China may join TPP talks

A spokesperson from the Ministry of Commerce (Mofcom) says that China will consider the costs and benefits of entering the TPP negotiations

The 17th round of negotiations of the Trans-Pacific Partnership took place in Peru last month between 12 countries including the United States, Singapore, Vietnam, Australia and New Zealand. Japan joined the talks a month ago.

"We will analyse the advantages, disadvantages and the possibility of joining the TPP, based on careful research and according to principles of equality and mutual benefit," said Shen Danyang of Mofcom.

Some groups have also raised concerns about some of the IP-related provisions in the TPP that have been leaked to the public.

Médecins Sans Frontières called the proposed agreement “the most harmful trade deal ever for access to medicines in developing countries”. According to MSF, one provision would require signatories to allow patents for “modifications of existing medicines, such as a new forms, uses or methods, even without improvement of therapeutic efficacy for patients”.

Some of the leaked provisions concerning copyright have also been criticised. Angela Daly of Swinburne University of Technology in Australia argued that article 4 of the TPP would implement what she describes as controversial aspects of the Digital Millennium Copyright Act, while the Electronic Frontier Foundation said that the TPP in its current form may restrict fair use and impose additional liability on internet service providers.

China’s absence from the TPP negotiations have been noted by some observers, who believe that such an agreement without the world’s second largest economy may be ineffective and would serve to isolate China.

more from across site and SHARED ros bottom lb

More from across our site

New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Gift this article